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Abstract
This review considers adipokines as predictive biomarkers for early onset post-traumatic knee
osteoarthritis (KOA). Serum concentrations of leptin and resistin can predict radiographic
changes and are elevated in early KOA, with higher leptin concentrations independently
associated with more severe knee changes. Plasma concentrations of resistin are chronically
elevated after injury. Leptin, resistin, chemerin and vistfatin induce catabolic enzymes
associated with cartilage degeneration. Available literature on adipokines in post-traumatic
KOA pathogenesis suggests that they could contribute to risk prediction of early onset
post-traumatic KOA. Further research is needed to further understand the association between
adipokines, synovitis and long-term outcomes in this population.
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Context
Adipokines are cytokines produced by white fat tissue in
response to a positive energy balance determined by food
intake. Obesity is a model of chronically elevated circulating
levels of pro-inflammatory adipokines. The biomechanical
aspects of increased body mass index (BMI) cannot explain the
high incidence of osteoarthritis (OA) in the non-weight-
bearing joints. Current concepts suggest that adipose tissue-
derived cytokines can increase inflammatory responses to
mechanical insults and result in fast progression to joint failure
(Oliveria et al., 1999). This article will review current literature
looking at the role of adipose tissue-associated inflammation in
the pathogenesis of post-traumatic knee osteoarthritis (KOA)
in the context of its impact on interactions between cartilage,
synovium and subchondral bone.
Methods
A comprehensive search of electronic databases was carried
out on Pubmed, the Cochrane Central Register of Controlled
Trials, CINAHL and reference lists of relevant articles. The
PubMed literature database was searched using MeSH index
terminology. The following broad search terms were included:
knee, post-traumatic and/or OA in combination with obesity,
adipokine or adiponectin. This was complimented by a hand
search of OA journals. This search was limited to human and
animal studies in the English language. Limits to publication
date applied between January 1985 and May 2014.
Systemic and local inflammation in post-traumatic
knee osteoarthritis
Systemic inflammation measured by IL-6 has been shown to
be an independent predictor of radiographic KOA in healthy,
middle-aged British women (Livshits et al., 2009). Knee
injury and obesity are strongly associated with the develop-
ment of KOA (Anderson & Felson, 1988; Davis et al., 1989;
Felson et al., 1988; Jiang et al., 2012; Lohmander et al., 2009;
Roos, 2005). Blagojevic et al. have estimated, through a meta-
analysis, that the overall pooled odd ratio (OR) for overweight
and obese individuals is 2.63 (95% CI 2.28–3.05) and 3.86
(95% CI 2.61–5.70) (Blagojevic et al., 2010) for those with
previous knee trauma. Obesity is characterized by high white
adipose tissue (WAT) mass and associated with a state of
chronic low-level inflammation. Anterior cruciate ligament
(ACL) or meniscal injuries are among the strongest risk
factors for early development of post-traumatic KOA
(Englund et al., 2003; Neuman et al., 2008; Roos, 2005;
von Porat, 2004). They represent a great model for the
development of KOA, with well-defined early onset of
disease. The incidence of all knee injuries is greatest in
males under 30 years of age (Gianotti et al., 2009; Majewski
et al., 2006). Joint injury may lead to a mild-to-moderate local
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inflammatory reaction (Pessler et al., 2008) and inflamed
knee synovium has been shown to be associated with more
severe cartilage degeneration over the course of a year (Ayral
et al., 2005). High systemic markers of inflammation have
been previously reported in patients with knee trauma
(Mendias et al., 2013).
Historically, the development of post-traumatic KOA in
humans with ACL-deficient knees has been mainly attributed
to recurrent episodes of knee instability. Primary ACL
reconstruction, aimed at restoring mechanical stability, has
not so far been proven to decrease the incidence of KOA or
improve long-term function in cohort or randomised con-
trolled studies (Barenius et al., 2014; Frobell et al., 2010,
2013; Lohmander et al., 2004; von Porat, 2004). It implies
that another mechanism might be responsible for driving joint
degeneration after initial trauma associated with instability.
Elevated BMI has been one of the strongest predictors of
early KOA development after ACL and/or meniscal injuries,
with an adjusted OR between 1.17 and 3.1 (Barenius et al.,
2014; Kessler et al., 2008; Lebel et al., 2008; Li et al., 2011).
Along with knee injury, other risk factors for the development
of KOA, age and female gender, are also associated with
increased systemic inflammation and a relatively higher
percentage of fat tissue (Pirkola et al., 2010).
The proposed overlapping common mechanism is an
adipose tissue-promoted inflammation. There is now increas-
ing evidence that, at least in a subset of the patients, both
inflammatory reactions of synovium and high adipokine
concentrations may be prevalent causes of early deterioration
of the knee joint (Guermazi et al., 2014; Karvonen-Gutierrez
et al., 2014; Roemer et al., 2011; Sokolove & Lepus, 2013). In
animal models, the effect of even extreme obesity on
development of KOA is diminished in animals without a
functional main adipokine pathway (Griffin et al., 2009).
Adipose tissue produces a series of chemicals that have
been linked with the regulation of systemic and organ-specific
inflammation, organ damage and chronic diseases like
diabetes (Bozaoglu et al., 2007; Fantuzzi, 2005;
MacDougald & Burant, 2007). It has been postulated that
increased systemic inflammation and activity of organ-
specific adipose stores promotes local inflammation. It has
also been suggested that, on the joint level, this results in
prolonged synovitis and affects the cartilage’s ability to
maintain an equilibrium between synthesis and degeneration
of cartilage constituents (Bao et al., 2010; de Boer et al.,
2012; Perruccio et al., 2014).
Signals from adipose tissue
Lipogenesis and lipolysis are two primary metabolic activities
of WAT (Cristancho & Lazar, 2011). Both processes are
regulated by endocrine and neural mechanisms. The discovery
of the first adipose tissue hormone, leptin, and an increased
interest in the endocrine functions of WAT have allowed for the
identification of cytokines known collectively as adipokines
(Ahima, 2006). The majority of these have been linked with
lipid metabolism but also with inflammation. Adipokines
associated with inflammation include classical pro-inflamma-
tory agents (IL-6, TNF-a) and tissue specific agents such as
leptin, adiponectin, Vaspin, Resistin, chemerin, visfatin and
adipsin. IL-6 produced by adipose tissue contributes to around
a third of circulating IL-6 and is strongly associated with
increasing obesity (Proenca et al., 2014).
Osteophytes are a structural hallmark of KOA and are
associated with knee pain. Individuals with higher BMIs have
an increased risk of fast cartilage loss (Roemer et al., 2009)
and report more severe knee pain (Weiss, 2014). High ratio of
fat mass to skeletal muscle mass is also positively associated
with more severe KOA structural changes on magnetic
resonance imaging (MRI) (Visser et al., 2014). Some
adipokines have been linked with development of more
severe knee changes (Karvonen-Gutierrez et al., 2014) and
more painful KOA (Perruccio et al., 2014). Similarly, patients
with a higher BMI are more likely to develop radiographic
KOA after anterior crucial ligament reconstruction (Li et al.,
2011). Secreted adipokines have also been shown to affect
bone cell differentiation and can potentially impact on bone
remodelling and bone formation (Bartell et al., 2011; Hamrick
et al., 2004; Muruganandan et al., 2010, 2013). Moreover,
bone marrow mesenchymal stem cells (MSCs) can differen-
tiate, not only into bone forming osteoblasts, but also into
adipocytes that can competitively suppress intracellular
osteogenic signals (Muruganandan & Sinal, 2014).
Leptin
Leptin is a hormone that is produced in proportion to WAT
mass and has been widely discussed in literature in the context
of pro-inflammatory properties in OA. Its concentration is
greater in women but it has not been entirely explained by
either adipose load or sex hormone concentrations (Licinio
et al., 1998). Apart from decreasing appetite, leptin promotes
neutrophil mobilisation, cytotoxic lymphocyte and macro-
phage activation (Carbone et al., 2012). It also enhances
production of MMP-1, MMP-3 and MMP-13 in human KOA
cartilage (Koskinen et al., 2011), resulting in a progressive
articular cartilage degeneration. The effect of leptin shows sex
dimorphism in the association of its effect with KOA. Higher
levels have been shown to be an independent predictor of MRI
and radiographic knee changes associated with OA, but
mainly in women.
Animal studies
Leptin has been shown to have both a strong anabolic and
catabolic function in chondrocytes. The anabolic function
occurs through the induction of IGF-1 and TGFb1 synthesis
(Dumond et al., 2003), while the catabolic function occurs by
inducing MMP1 and MMP13 expression with a concomitant
activation of STAT, MAPK, Akt and NF-kB signalling
pathways (Hui et al., 2012). Diet-induced obesity in mice
increases serum concentrations of leptin and KOA scores
(Griffin et al., 2012). Moreover, extreme obesity in animals
with impaired leptin signalling (leptin or leptin receptor
deficient) does not cause increased incidence of KOA (Griffin
et al., 2009). Leptin also affects bone metabolism and central
injection (intra-cerebroventricular administration) leads to
enhanced bone formation in a mutant leptin-deficient mouse
model (ob/ob mice) (Bartell et al., 2011).
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Human studies
Leptin receptors have been found to be expressed in articular
chondrocytes (Figenschau et al., 2001) and modulate expres-
sion of canonical Wnt signalling receptors (Ohba et al., 2010).
Synovial fluid (SF) and serum concentrations correlate with
BMI in patients with established KOA, while SF/serum ratio
is higher in early KOA (de Boer et al., 2012; Dumond et al.,
2003; Staikos et al., 2013). Unlike other adipokines, leptin
concentrations in SF are similar or higher than serum
concentrations (Presle et al., 2006). Higher plasma concen-
trations have been associated with greater painful joint burden
(Perruccio et al., 2014), with prevalent and incident KOA (OR
1.31, 95% CI 1.21–1.41), over a 10-year period in middle-
aged women (Karvonen-Gutierrez et al., 2013). In a 5-year
cohort study with very early-stage KOA, leptin has been
shown to be associated with higher levels of systemic markers
of synovial and cartilage metabolism and progression but not
with the incidence of radiographic KOA (Van Spil et al.,
2012). It has been cross-sectionally and longitudinally
associated with reduced cartilage thickness (Stannus et al.,
2013) and, interestingly, both obesity and female gender
effects have mainly been related to leptin (Ding et al., 2008).
Baseline levels have been associated with increased levels of
bone formation biomarkers (over 2 years) in patients with
established KOA (Berry et al., 2011). These have been
correlated with larger osteophyte formation, synovitis and
effusion on MRI (Karvonen-Gutierrez et al., 2014). Recently,
in women, higher leptin has been associated with 30%
higher risk of having structural KOA (Karvonen-Gutierrez
et al., 2012).
In summary, serum leptin levels have been positively
linked with KOA on a molecular level and in vivo,
both in animal models and human clinical studies.
This review has not identified any studies looking at the
role of leptin specifically in the development of post-
traumatic KOA.
Adiponectin
This adipokine modulates insulin sensitivity and inflamma-
tion. It has been shown to have both anti- and pro-
inflammatory properties, but its pivotal role is associated
with an inhibitory effect of proinflammatory cytokines, such
as tumour necrosis factor and interleukin-6 (IL-6). It is also
associated with the induction of expression of anti-inflam-
matory proteins, including IL-10 and IL-1 receptor antagonist
(Kumada et al., 2004; Tsatsanis et al., 2005; Wolf et al.,
2004). Females have higher circulating levels of adiponectin
than males (Combs et al., 2003). Visceral adipocytes are
mainly responsible for adiponectin’s systemic levels and,
paradoxically, those are reduced in obesity (Arita et al., 2012).
The transcription of adiponectin in adipocytes is suppressed
by TNF and IL-6, which might explain the lower levels of
serum adiponectin in obese individuals (Bruun et al., 2003;
Fasshauer et al., 2003; Maeda et al., 2002). Two types of
adiponectin receptor have been identified: AdipoR1, which
mainly activates the AMPK phosphorylation pathway and
AdipoR2, which is involved in the activation of PPAR-a (Lee
et al., 2008).
Animal studies
Adiponectin is effective in reducing the activation of
inflammatory pathways, including the NF-kB pathway
(Lira et al., 2012). Diet-induced obesity has been shown to
significantly increase the severity of post-traumatic KOA in a
common inbred strain of laboratory mice. More importantly,
levels of synovial inflammation in controlled uninjured knees
inversely correlates with systemic levels of adiponectin
(Louer et al., 2012).
Human studies
Adiponectin has not been detected in healthy cartilage and is
up-regulated in patients with OA (Francin et al., 2014). It has
been shown to be weakly associated with synovial inflam-
mation in patients with end-stage KOA (de Boer et al., 2012).
In human chondrocytes cultures, adiponectin induces MMP-3
(Tong et al., 2011). In patients with hand OA, high levels of
adiponectin have been associated with a 70% reduction of
joint space narrowing over a 6-year period (Yusuf et al.,
2011). Development of early symptomatic KOA has been
negatively associated with levels of adiponectin, and posi-
tively with high-sensitivity CRP (hs-CRP). Levels of
adiponectin have not been shown to predict progression or
incidence of radiographic KOA (Van Spil et al., 2012).
Decreased levels in both plasma and SF have been shown to
be lower in more advanced KOA, indicating that it may have a
protective role (Honsawek & Chayanupatkul, 2010).
Adiponectin has not been linked with an increase of bone
formation biomarkers so far (Berry et al., 2011).
In summary, higher systemic concentrations of adiponectin
probably protect against development of KOA in animal
models, while some clinical human studies also confirm
these properties. Despite this, adiponectin’s role in the
regulation of joint inflammation and cartilage homeostasis
is still not clear.
Resistin
The adipocytokine resistin was initially investigated mainly as
an insulin resistance inducing factor in mice (Steppan et al.,
2001). The receptor for resistin is unknown, but it has strong
pro-inflammatory properties and has been shown to trigger
the release of other proinflammatory cytokines such as
TNF- a, IL-1b and IL-6 (Bokarewa et al., 2005).
Human studies
Serum resistin is elevated in obese individuals (Degawa-
Yamauchi, 2003) but this correlation is obscured in patients
with advanced KOA (de Boer et al., 2012). In humans, resistin
correlates better with subclinical inflammation than with
insulin resistance (Steppan & Lazar, 2002). Resistin can be
detected locally in the synovium of patients with KOA and
correlates with histologically defined synovitis (de Boer et al.,
2012). Both systemic and SF concentrations are elevated in
post-traumatic knees and associated with the release of
cytokines and cartilage degeneration (Lee et al., 2009). In a
very early symptomatic KOA cohort, resistin levels have been
shown to be positively associated with synovial biomarkers
(sPIIINP) and high-sensitivity CRP but, more interestingly,
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with the incidence of radiographic KOA (Van Spil et al.,
2012). Such findings are independent of BMI and testing hs-
CRP as a potential confounder in this association has
suggested that those processes are independent.
Adipsin
Adipsin is involved in triglyceride metabolism but its effect
on cartilage and the rest of the knee joint is not yet known,
including any role in the modulation of synovitis after joint
trauma. Higher adipsin levels have been found in obese
individuals (Abu-Farha et al., 2014; Bienertova-Vasku et al.,
2014). Lower serum concentrations of adipsin have been
associated with greater painful joint burden in patients with
end-stage hip and knee OA (Perruccio et al., 2014).
Chemerin
Chemerin is a novel adipokine that affects adipocyte differen-
tiation and metabolism in vitro (MacDougald & Burant, 2007).
It acts through G protein-coupled receptor: the chemokine like
receptor-1 (CMKLR1, also known as ChemR23) and is
expressed by circulating plasmacytoid dendritic cells, tissue-
resident macrophages and adipocytes. It has been postulated
that chemerin increases macrophage infiltration and activates a
local inflammatory response (Goralski et al., 2007).
Stimulating human chondrocytes with chemerin results in an
increase in phosphorylation of Akt and a probable subsequent
activation of MEK1/2. It also further activates the MAPK
pathway and increases concentration of TNF-a, IL-1b, IL-6
and IL-8 (Berg et al., 2010). Along with this, it increases Toll-
like receptor 4 mRNA and the synthesis of CCL2 in OA
synoviocytes (Eisinger et al., 2012). The activated Toll-like
receptor 4 leads to the development of an inflammatory
reaction involving macrophages. CCL2 has been linked with
mediating movement-related pain signalling in the animal
model of post-traumatic KOA (Miller et al., 2012).
Animal studies
Mice bone marrow–derived osteoblast precursor cells differ-
entiate to adipocytes when stimulated by chemerin
(Muruganandan & Sinal, 2014). The increased bone mineral-
ization with chemerin, in the CMKLR1 knockdown model,
suggests that this signalling pathway acts, not only to promote
adipogenesis, but also to actively suppress osteoblastogenesis.
Human studies
Chemerin has been associated with visceral obesity (Shin
et al., 2012). High levels have been found to be associated
with the activity of inflammatory arthritis (rheumatoid and
psoriatic) (Ha et al., 2014; Xue et al., 2012). Chemerin is
detected in SF and its higher concentrations are associated
with KOA severity (Huang et al., 2012). SF levels of
chemerin are similar in patients with KOA, rheumatoid and
psoriatic arthritis (Valcamonica et al., 2014). Human chon-
drocyte cultures from patients with recent ACL injuries and
end-stage KOA cells have been positive for both ChemR23
and chemerin staining (Berg et al., 2010). Stimulation of those
cultures with chemerin has resulted in a significant elevation
of MMP-1, MMP-2, MMP-3, MMP-8 and MMP-13 levels,
catabolic enzymes associated with cartilage degeneration.
Visfatin
Visfatin is called pre-B-cell colony-enhancing factor and is
mainly produced by adipocytes in visceral fat and associated
with increases in insulin resistance (Fukuhara et al., 2005).
It regulates intracellular activity of the NAD-consuming
enzymes affecting the production of inflammatory cytokines
(TNFa, IL-6 and IL-1b) (Moschen et al., 2010). So far, no
specific receptor has been identified, but it is thought that
visfatin exerts proinflammatory action by regulating the
insulin receptor pathway activity (Jacques et al., 2012).
Human chondrocytes stimulated with visfatin induce synthe-
sis of MMP-3 and MMP-13 (Gosset et al., 2008).
Human studies
Higher levels are observed in subjects with broader waists
(Bienertova-Vasku et al., 2014) and associated with higher
triglicerides but lower HDL (Abu-Farha et al., 2014). Patients
with rheumatoid arthritis have higher serum levels of visfatin
than healthy controls (Otero et al., 2006). Vistafin has been
also shown to be produced and stored by synovial membrane,
cartilage and the subchondral bone in patients with KOA
(Laiguillon et al., 2014).
Summary
Animal research in this field, assessing the role of pro-
inflammatory cytokines related to adipose tissue in the
development of post-traumatic OA (PTOA), is very promis-
ing. Animals with impaired leptin pathways do not develop
KOA, even in the presence of extreme obesity, indicating that
increased loading cannot explain cartilage degeneration alone.
Higher leptin levels have been associated with more severe
progression of knee joint degeneration.
Leptin, resistin, chemerin and vistfatin have all been shown
to induce chondrocyte production of matrix metalloprotei-
nases. Based on the available literature on the involvement of
adipokines in post-traumatic KOA pathogenesis, it is plaus-
ible that adipokines (especially leptin in women), resistin and
chemerin (in men and women) may, in the future, contribute
to a risk model of early development of KOA after ACL
and/or meniscal injury. The relative activity of the various
adipokines with respect to their effects on the synovium, bone
and cartilage after knee trauma remains to be determined.
Local changes in adipokine concentrations may have import-
ant pathophysiological implications for cartilage homeostasis
but, so far, only leptin seems to correlate well with SF
concentration and the systematic elevation of resistin levels
has been proven to reflect SF concentration after joint injury.
This review identifies the need for prospective cohort
studies to investigate the role of serum and SF adipokines as
potential biomarkers for early post-traumatic OA in patients
with acute ACL and/or meniscal injuries. Long-term follow-
up will help to identify those at risk of a poor outcome and
identify possible therapeutic targets in this pathway.
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